Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP410931.RAczfWm5d0uANVQm3AfRi6TPRXoZ0UKVUfqIUntB3gRCw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP410931.RAczfWm5d0uANVQm3AfRi6TPRXoZ0UKVUfqIUntB3gRCw130_assertion type Assertion NP410931.RAczfWm5d0uANVQm3AfRi6TPRXoZ0UKVUfqIUntB3gRCw130_head.
- NP410931.RAczfWm5d0uANVQm3AfRi6TPRXoZ0UKVUfqIUntB3gRCw130_assertion description "[Amplification of ERBB-2 was detected in 14 out of 63 (22%) cases of breast carcinoma, in 1 out of 23 patients with ovarian cancers, in 1 out of 19 cases of colon carcinoma and in 1 out of 27 patients with thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410931.RAczfWm5d0uANVQm3AfRi6TPRXoZ0UKVUfqIUntB3gRCw130_provenance.
- NP410931.RAczfWm5d0uANVQm3AfRi6TPRXoZ0UKVUfqIUntB3gRCw130_assertion evidence source_evidence_literature NP410931.RAczfWm5d0uANVQm3AfRi6TPRXoZ0UKVUfqIUntB3gRCw130_provenance.
- NP410931.RAczfWm5d0uANVQm3AfRi6TPRXoZ0UKVUfqIUntB3gRCw130_assertion SIO_000772 1349430 NP410931.RAczfWm5d0uANVQm3AfRi6TPRXoZ0UKVUfqIUntB3gRCw130_provenance.
- NP410931.RAczfWm5d0uANVQm3AfRi6TPRXoZ0UKVUfqIUntB3gRCw130_assertion wasDerivedFrom befree-2016 NP410931.RAczfWm5d0uANVQm3AfRi6TPRXoZ0UKVUfqIUntB3gRCw130_provenance.
- NP410931.RAczfWm5d0uANVQm3AfRi6TPRXoZ0UKVUfqIUntB3gRCw130_assertion wasGeneratedBy ECO_0000203 NP410931.RAczfWm5d0uANVQm3AfRi6TPRXoZ0UKVUfqIUntB3gRCw130_provenance.